Canada has shifted from importing fentanyl to making it
This metric measures the supply side — domestic fentanyl production — that border-seizure data cannot see. Over the past several years Canada moved from importing finished fentanyl to manufacturing it domestically from imported precursor chemicals, at a scale that now exceeds what the domestic market could absorb: the signature of an export industry. Counting what crosses the border (the companion cross-border crime metric) measures the wrong thing here; this page measures production.
Related metrics. This is one strand of the illicit-economy and border-security picture. See also:
Border integrity — who Canada admits and whether departures are tracked.
Cross-border crime — the contraband — cocaine and firearms — moving across the border.
Human trafficking — reported trafficking trends, which are largely domestic.
Money laundering — Canada's exposure to illicit financial flows.
After China regulated fentanyl and its analogues in 2019, finished-fentanyl seizures at Canada's border fell — but seizures of precursor chemicals rose roughly tenfold. Organized crime had moved the manufacturing onshore. The Fentanyl Czar's 2025 interim report is explicit: "most of the large seizures of fentanyl in Canada can be linked to domestic production that arise from illegally imported or diverted precursor chemicals." The result is a production base whose capacity, on the evidence of recent superlab busts, far outstrips anything Canadians alone could consume — which is the definition of an export industry.
One BC superlab's fentanyl capacity
95.5M doses
Potentially lethal doses from fentanyl plus precursors at the Falkland, BC site (Oct 2024) — about 2.3× Canada's population. RCMP said output far exceeded domestic demand.
Fentanyl-production sites dismantled, 2018–2023
40
Health Canada supports dismantling ~25 clandestine labs a year, about a fifth of them fentanyl-synthesis sites — concentrated in the western provinces and Ontario.
Opioid-toxicity deaths, 2024
7,146
About 20 Canadians a day; 74% involved fentanyl. Some 52,544 have died since 2016 — the harm this supply feeds.
The reframe. A low fentanyl figure at the border does not mean Canada has a small fentanyl problem — it means the problem is no longer one of importing the finished drug. Production has moved inside the country, and the output increasingly outstrips what Canadians could consume. Seizure-at-the-border metrics, by construction, cannot capture this; that is exactly why fentanyl is measured here rather than on the cross-border crime page.
Capacity that outstrips the country
The clearest single illustration came from Falkland, British Columbia, in October 2024, where the RCMP dismantled what it called the largest, most sophisticated drug superlab in Canadian history. The fentanyl and precursor chemicals seized at that one site equated to roughly 95.5 million potentially lethal doses — enough, the RCMP noted, to kill every Canadian about twice over. No domestic market can absorb that. RCMP stated the output far exceeded local demand, and the charges laid included exporting.
One superlab's fentanyl capacity vs Canada's population (potentially lethal doses, and people)
Source: RCMP, "Federal investigators take down the largest, most sophisticated drug superlab in Canada" (Falkland, BC; 25 October 2024) — 54 kg fentanyl plus precursors/supplies equating to ~95,500,000 potentially lethal doses. Canada's population ≈ 41.5 million (Statistics Canada, mid-2024). The dose figure is potential capacity from one site, not an annual production estimate — it is shown to convey scale relative to the population, not as a yearly output.
The toll at home
Production and export are the security story; the public-health story is the death toll the same drug drives inside Canada. Apparent opioid-toxicity deaths climbed from 2,832 in 2016 to a peak of 8,606 in 2023 before easing to 7,146 in 2024 — still about 20 deaths a day, with fentanyl involved in nearly three-quarters of them. The 2024 dip is real but leaves deaths at more than double their pre-2020 level.
Apparent opioid-toxicity deaths, Canada, 2016–2024 (number of deaths)
Source: Public Health Agency of Canada, via Canada's Fentanyl Czar Interim Report (June 2025). 74% of 2024 deaths involved fentanyl. Deaths peaked at 8,606 in 2023 and eased to 7,146 in 2024. The report cites 52,544 cumulative deaths (Jan 2016–Dec 2024); the annual figures shown sum slightly lower owing to provincial data revisions.
Findings
Finding 1
From importer to producer
China's 2019 regulation of fentanyl cut finished-drug imports, but precursor-chemical seizures rose roughly tenfold as production moved onshore. The Fentanyl Czar's report states most large Canadian fentanyl seizures now trace to domestic production from imported or diverted precursors.
Finding 2
Capacity built for export
The Falkland, BC superlab alone yielded fentanyl and precursors equal to 95.5 million potentially lethal doses — about 2.3× Canada's population, valued near $485M. RCMP said output far exceeded local demand; charges included exporting. Canada-sourced fentanyl has surfaced in markets including the US and Australia.
Finding 3
Systemic, not a one-off
Falkland was the largest, but not the only, lab. Health Canada's Drug Analysis Service supports dismantling about 25 clandestine labs a year — roughly a fifth fentanyl-synthesis — and 40 fentanyl-production sites were taken down between 2018 and 2023, concentrated in the western provinces and Ontario.
Finding 4
A severe and entrenched toll
Opioid-toxicity deaths peaked at 8,606 in 2023 and eased to 7,146 in 2024 — still ~20 a day and over double the pre-2020 level, with 52,544 dead since 2016. Production capacity and export reach are growing even where the death curve has plateaued, which is why the verdict is Weak.
What this measures. The production/source side of fentanyl — manufacturing capacity, precursor inflows, and export evidence — not interdiction of the finished drug at the border (that is the cross-border crime metric).
Capacity is not annual output. The 95.5M-dose figure is potential capacity from finished fentanyl plus precursors and supplies seized at one site; it illustrates scale against a ~41.5M population, and is not an estimate of annual national production.
Lab data are episodic. Health Canada's Drug Analysis Service supports dismantling roughly 25 clandestine labs a year (about a fifth fentanyl-synthesis); 40 fentanyl-production sites were dismantled 2018–2023. These are enforcement events, not a continuous production series, so they are cited as context rather than charted as a trend.
Deaths measure harm, not production. The opioid-toxicity series is shown as the human stakes the supply feeds; it reflects demand and toxicity, not how much is manufactured.
No cross-country or border-flow comparison. Fentanyl production is not measured comparably across countries, and border-seizure figures (in either direction) understate a production-and-export problem, so they are deliberately not charted here.
Companion workbook. The editable series live in Securing_Fentanyl-Production_Data.xlsx: production/source evidence and the opioid-death series.
Page last reviewed June 2026 · Data current to June 2025 — the latest Fentanyl Czar interim report